$1.55 Billion is the total value of BRIDGER MANAGEMENT, LLC's 38 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CGIX | Exit | CANCER GENETICS INC | $0 | – | -52,508 | -100.0% | -0.01% | – |
| WW | Exit | WEIGHT WATCHERS INTL INC NEW | $0 | – | -123,831 | -100.0% | -0.12% | – |
| WW | Exit | WEIGHT WATCHERS INTL INC NEWput | $0 | – | -300,000 | -100.0% | -0.30% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -341,121 | -100.0% | -0.50% | – |
| SPNE | Exit | SEASPINE HLDGS CORP | $0 | – | -618,684 | -100.0% | -0.63% | – |
| SGMS | Exit | SCIENTIFIC GAMES CORPcl a | $0 | – | -1,632,180 | -100.0% | -1.06% | – |
| TV | Exit | GRUPO TELEVISA SAspon adr rep ord | $0 | – | -648,825 | -100.0% | -1.23% | – |
| STJ | Exit | ST JUDE MED INC | $0 | – | -911,008 | -100.0% | -3.46% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -390,016 | -100.0% | -3.48% | – |
| CHTR | Exit | CHARTER COMMUNICATIONS INC Dcl a new | $0 | – | -253,822 | -100.0% | -3.55% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.